CIPROFLOXACIN THERAPY OF EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS

被引:17
作者
FERNANDEZGUERRERO, M
ROUSE, M
HENRY, N
WILSON, W
机构
[1] MAYO CLIN & MAYO FDN,MAYO MED SCH,ROCHESTER,MN 55905
[2] FDN JIMENEZ DIAZ,MADRID 3,SPAIN
关键词
D O I
10.1128/AAC.32.5.747
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:747 / 751
页数:5
相关论文
共 23 条
[1]   SINGLE OR COMBINATION THERAPY OF STAPHYLOCOCCAL ENDOCARDITIS IN INTRAVENOUS DRUG-ABUSERS [J].
ABRAMS, B ;
SKLAVER, A ;
HOFFMAN, T ;
GREENMAN, R .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) :789-791
[2]   STAPHYLOCOCCAL BACTEREMIA AND ENDOCARDITIS - STATE OF THE ART [J].
BAYER, AS .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (06) :1169-1177
[3]   EFFICACY OF VANCOMYCIN PLUS RIFAMPIN IN EXPERIMENTAL AORTIC-VALVE ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - INVITRO INVIVO CORRELATIONS [J].
BAYER, AS ;
LAM, K .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (01) :157-165
[4]   EFFICACY OF CIPROFLOXACIN FOR EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS [J].
CARPENTER, TC ;
HACKBARTH, CJ ;
CHAMBERS, HF ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :382-384
[5]   STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - CLINICAL MANIFESTATIONS IN ADDICTS AND NONADDICTS [J].
CHAMBERS, HF ;
KORZENIOWSKI, OM ;
SANDE, MA .
MEDICINE, 1983, 62 (03) :170-177
[6]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[7]   PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].
CRUMP, B ;
WISE, R ;
DENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786
[8]   EFFICACY OF IMIPENEM CILASTATIN IN ENDOCARDITIS [J].
DICKINSON, G ;
RODRIGUEZ, K ;
ARCEY, S ;
ALEA, A ;
GREENMAN, R .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6A) :117-121
[9]  
DIXON WJ, 1969, INTRO STATISTICAL AN, P167
[10]   INVITRO ACTIVITY OF CIPROFLOXACIN, A NEW CARBOXYQUINOLINE ANTIMICROBIAL AGENT [J].
ELIOPOULOS, GM ;
GARDELLA, A ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :331-335